Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07458191) titled 'Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation' on March 4.

Study Type: Observational

Primary Sponsor: Bosnalijek D.D

Condition: Nonvalvular Atrial Fibrillation

Intervention: Drug: Apixaban

Recruitment Status: Recruiting

Date of First Enrollment: October 9, 2025

Target Sample Size: 800

Countries of Recruitment: Bosnia and Herzegovina

To know more, visit https://clinicaltrials.gov/study/NCT07458191

Disclaimer: Curated by HT Syndication....